<DOC>
	<DOCNO>NCT02812433</DOCNO>
	<brief_summary>Despite improvement neonatal care , birth asphyxia term newborn remain serious condition cause significant mortality long-term morbidity , include cerebral palsy mental retardation . Currently , treatment exists repair brain injury secondary neonatal asphyxia . The available treatment condition hypothermia may prevent repair development brain injury . The success therapy limit . Sildenafil already use newborn purpose ( i.e. , persistent pulmonary hypertension ) , , surprisingly , effect newborn brain never study systematically . The finding investigator rat model term neonatal encephalopathy demonstrate administration sildenafil follow asphyxia promotes brain injury recovery . Thus , investigator hypothesize sildenafil may improve neurodevelopmental outcome term asphyxiate newborn , hypothermia treatment fail prevent development brain injury .</brief_summary>
	<brief_title>Sildenafil Administration Treat Neonatal Encephalopathy</brief_title>
	<detailed_description>Before able run large multicenter randomize trial prove hypothesis , investigator need run phase Ib pilot trial ensure feasibility safety use sildenafil population newborn . Thus , phase Ib study , investigator hypothesize sildenafil safely used term asphyxiate newborn treat hypothermia . The investigator test hypothesis follow specific aim : 1 . Safety ( primary ) : ensure sildenafil safely use asphyxiate newborns treated hypothermia ; 2 . Tolerability ( secondary ) : study pharmacokinetics pharmacodynamics sildenafil newborn ; 3 . Efficacy ( exploratory ) : determine whether sildenafil improves neurodevelopment 2 year age , decrease brain injury day 30 life decrease neuroinflammation .</detailed_description>
	<mesh_term>Brain Diseases</mesh_term>
	<mesh_term>Sildenafil Citrate</mesh_term>
	<criteria>Male female asphyxiate newborn meet criterion induce hypothermia : Gestational age ≥ 36 week birth weight ≥ 1800 g Evidence fetal distress , history acute perinatal event , cord pH ≤ 7.0 base deficit ≤ 16 mEq/L Evidence neonatal distress , Apgar score ≤ 5 10 minute , postnatal blood gas pH obtain within first hour life ≤ 7.0 base deficit ≤ 16 mEq/L , continue need ventilation initiate birth continue least 10 minute Evidence moderate severe neonatal encephalopathy abnormal neurological exam and/or amplitudeintegrated electroencephalogram ( aEEG ) These newborn receive wholebody cool esophageal temperature 33.5°C , initiate within first 6 hour life , continue 72 hour , slowly rewarmed use standard protocol . Evidence brain MRI perform day 2 life ( treated hypothermia ) type brain parenchymal injury pattern typically encounter asphyxiated newborn . If meet criterion hypothermia treatment demonstrate brain injury day 2 life , randomize sildenafil placebo treatment . Newborns complex congenital heart disease Newborns cerebral malformation Newborns genetic syndrome Newborns intraventricular and/or intraparenchymal hemorrhage MRI perform day 2 life Moribund infant expect survive</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>48 Hours</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>birth asphyxia</keyword>
	<keyword>brain</keyword>
	<keyword>hypoxic-ischemic encephalopathy</keyword>
	<keyword>neonate</keyword>
	<keyword>neuroprotection</keyword>
	<keyword>neurorestoration</keyword>
	<keyword>newborn</keyword>
	<keyword>sildenafil</keyword>
</DOC>